Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Chronic obstructive pulmonary disease - Management
Short-acting antimuscarinic (ipratropium): nebules

Age from 16 years onwards
Ipratropium nebules: 250mcg up to four times a day
Ipratropium bromide 250micrograms/ml nebuliser liquid 1ml unit dose vials
Inhale the contents of one vial (250micrograms) using the nebuliser up to four times a day.
Supply 20 1ml vial.
Age: from 16 years onwards
NHS cost: £4.14
Licensed use: yes
Ipratropium nebules: 500mcg up to four times a day
Ipratropium bromide 250micrograms/ml nebuliser liquid 2ml unit dose vials
Inhale the contents of one vial (500micrograms) using the nebuliser up to four times a day.
Supply 20 2ml vials.
Age: from 16 years onwards
NHS cost: £4.87
Licensed use: yes

© NHS Institute for Innovation and Improvement